Proposes a new method that improves sequence realism in nanobody design, indicating enhanced antibody engineering outcomes.
Aim Nanobodies are single-domain antibodies with promising therapeutic potential, yet accurate complementarity-determining region (CDR) design remains challenging. Methods Existing diffusion-based frameworks such as DiffAb[1] and RFantibody[2] typically generate CDR sequences on fixed scaffolds by enforcing structural and physical constraints, but they neglect evolutionary information intrinsic to antibody repertoires. We propose a scaffold-constrained diffusion framework that integrates a nativeness prior, guiding generation toward sequences that are not only structurally consistent but also evolutionarily plausible. Results By incorporating nativeness-aware constraints during design, our model produces nanobody candidates that better balance physical compatibility with natural repertoire characteristics, achieving improved sequence realism and developability. Conclusion This approach provides a new computational strategy for antibody engineering, enabling more realistic and efficient nanobody design. References 1. Luo S., Su Y., Peng X., Wang S., Peng J., Ma J. ‘Antigen-specific antibody design and optimization with diffusion-based generative models for protein structures.’ Advances in Neural Information Processing Systems 2022. 2. Bennett N.R., Watson J.L., Ragotte R.J., Borst A.J., See D.L., Weidle C., Biswas R., Shrock E.L., Leung P.J.Y., Huang B., Goreshnik I., Ault R., Carr K.D., Singer B., Criswell C., Vafeados D., Garcia Sanchez M., Kim H.M., Vázquez Torres S., Chan S., Baker D. ‘Atomically accurate de novo design of single-domain antibodies.’ bioRxiv 2024.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: